6883
Jiangsu Bioperfectus Technologies Co., Ltd. (688399)
Market Closed
12 Dec, 06:57
SSE SSE Primary ¥
64. 83
-0.77
-1.17%
¥
3.82B Market Cap
- P/E Ratio
40% Div Yield
907,597 Volume
- Eps
¥ 65.6
Previous Close Day Range
64.5 66.08
Year Range
38.73 80.3
Want to track 688399 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
688399 closed Friday lower at ¥64.83, a decrease of 1.17% from Thursday's close, completing a monthly decrease of -5.96% or ¥4.11. Over the past 12 months, 688399 stock gained 46.81%.
688399 pays dividends to its shareholders, with the most recent payment made on Sep 11, 2025. The next estimated payment will be in In 8 months on Sep 11, 2026 for a total of ¥3.4.
The last earnings report, released on May 23, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Jiangsu Bioperfectus Technologies Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jun 13, 2025.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on SSE (CNY).
Jiangsu Bioperfectus Technologies Co., Ltd. (688399) FAQ
What is the stock price today?
The current price is ¥64.83.
On which exchange is it traded?
Jiangsu Bioperfectus Technologies Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 688399.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 40%.
What is its market cap?
As of today, the market cap is 3.82B.
Has Jiangsu Bioperfectus Technologies Co., Ltd. ever had a stock split?
Jiangsu Bioperfectus Technologies Co., Ltd. had 1 splits and the recent split was on Jun 13, 2025.
Jiangsu Bioperfectus Technologies Co., Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Dr. Guoqiang Wang CEO | SSE Exchange | CNE1000055B2 ISIN |
| CN Country | 684 Employees | 11 Sep 2025 Last Dividend | 13 Jun 2025 Last Split | - IPO Date |
Overview
Jiangsu Bioperfectus Technologies Co., Ltd. is a prominent figure in the molecular diagnostics field, dedicated to enhancing healthcare through innovative diagnostics solutions. Since its inception in 2010, the company has been deeply involved in the research, development, manufacturing, and marketing of in vitro diagnostic (IVD) products within China. Based in Taizhou, China, Bioperfectus stands out for its commitment to developing diagnostic technologies that address a wide range of infectious diseases and other medical conditions, aiming to deliver accurate, efficient, and reliable solutions for professionals and patients alike.
Products and Services
Jiangsu Bioperfectus Technologies Co., Ltd. provides a comprehensive array of products and services in the molecular diagnostics landscape:
- In Vitro Diagnostic Reagents: These reagents are crucial for detecting and quantifying substances in samples taken from the human body. Bioperfectus offers a diverse portfolio of diagnostic reagents that facilitate the accurate diagnosis of infectious diseases, genetic disorders, and other conditions.
- Supporting Testing Equipment: Alongside its diagnostic reagents, the company supplies sophisticated testing equipment designed to perform a wide range of in vitro diagnostic tests. This equipment is integral to ensuring the reliability and efficiency of the testing process in clinical settings.
- In Vitro Testing Services: Bioperfectus extends its expertise beyond products by offering specialized testing services. These services are aimed at assisting healthcare providers and laboratories in conducting precise and timely diagnostic tests, thereby enhancing patient care and treatment outcomes.
Contact Information
Address: Bioperfectus Technologies Industrial Par, Taizhou, China, 225300
Phone: 86 52 3802 25599
Website: https://www.s-sbio.com
2025 © Marketlog. All Rights Reserved.
